Alphabet's AI drug discovery subsidiary Isomorphic Labs secures $600 million funding from Thrive Capital to accelerate development of its AI-powered drug design platform and advance its drug candidates into clinical trials, leveraging technology like DeepMind's AlphaFold.
An AI algorithm trained on 80,000 cases optimizes intravenous nutrition for premature babies, reducing medical errors and costs while enhancing care efficiency and accessibility by assisting doctors in making better clinical decisions for this vulnerable population.
Oracle, a tech giant, is grappling with two data breaches: one involving unauthorized access to patient data from its healthcare division, and another where a hacker claims to have accessed authentication data for millions of Oracle Cloud customers, raising concerns about cloud security.
The bankruptcy of 23andMe, a DNA testing company, sparked widespread fears about the potential sale of millions of Americans' genetic data to the highest bidder, prompting a surge in traffic as users rushed to delete their data and raising concerns about data privacy and national security risks.
Amazon is pushing into generative AI with new conversational shopping and health assistants, including 'Interests AI' for product recommendations and a chatbot offering medical advice and wellness guidance.
Ant Group strategically combines Chinese and U.S. semiconductors for cost-effective AI development, enhancing its healthcare solutions by leveraging a 'mixture of experts' technique, with upgraded AI models being adopted by major Chinese hospitals.
AI technology is transforming mental health care, enhancing accessibility through 24/7 availability, aiding early diagnosis through data analysis, and supporting therapists with insights and task automation, yet human empathy and ethical oversight remain crucial.
A groundbreaking mRNA vaccine demonstrated remarkable potential in preventing pancreatic cancer recurrence, with some patients remaining cancer-free for over 3 years in a small clinical trial, offering new hope by training the immune system to recognize and attack cancer cells.
Google unveils AI-powered health search enhancements, APIs for medical data sharing, and an FDA-cleared cardiac arrest detection feature on the Pixel Watch 3, showcasing its commitment to improving healthcare through innovative technologies.
TxAgent, an AI agent leveraging multi-step reasoning and real-time biomedical knowledge retrieval, revolutionizes personalized drug treatment with 92.1% accuracy, outperforming leading models and ensuring treatment recommendations align with clinical guidelines to reduce adverse events.